Bridgeway Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bridgeway Capital Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-398,043	Closed	-$908K	–	1338
2024 Q2	$908K	Buy	398,043 +206,900	+108%	+$790K	0.02%	716
2024 Q1	$826K	Buy	191,143 +71,143	+59%	+$248K	0.02%	791
2023 Q4	$366K	Sell	120,000 -20,000	-14%	-$37.6K	0.01%	1018
2023 Q3	$202K	Buy	140,000 +25,000	+22%	+$48.4K	﹤0.01%	1099
2023 Q2	$286K	Buy	+115,000	New	+$314K	0.01%	1058

Bridgeway Capital Management's GTHX Position: Q3 2024 in Review

Bridgeway Capital Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 398,043 shares — an estimated $908K sold.

Bridgeway Capital Management first reported a position in GTHX in Q2 2023 and held it in 5 quarters. The position peaked at $908K in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Bridgeway Capital Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Bridgeway Capital Management sold 398,043 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $908K.
Bridgeway Capital Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2023 and held it in 5 quarters.
Bridgeway Capital Management's G1 Therapeutics, Inc. Common Stock position peaked at $908K in Q2 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Bridgeway Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.